S
XLRN

SignatureFD’s Acceleron Pharma XLRN Stock Holding History

SignatureFD’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-42
Closed -$7K – 3370
2021
Q3 		$7K Sell
42
-31
-42% -$4.05K ﹤0.01% 2264
2021
Q2 		$9K Sell
73
-6
-8% -$757 ﹤0.01% 2061
2021
Q1 		$11K Buy
79
+32
+68% +$4.13K ﹤0.01% 1842
2020
Q4 		$6K Buy
+47
New +$5.51K ﹤0.01% 1929
2020
Q3 		– Sell
-58
Closed -$6K – 2827
2020
Q2 		$6K Buy
58
+18
+45% +$1.74K ﹤0.01% 1766
2020
Q1 		$4K Buy
40
+21
+111% +$1.63K ﹤0.01% 1774
2019
Q4 		$1K Hold
19
– – ﹤0.01% 2155
2019
Q3 		$1K Hold
19
– – ﹤0.01% 2055
2019
Q2 		$1K Buy
+19
New +$787 ﹤0.01% 1992

SignatureFD's XLRN Position: Q4 2021 in Review

SignatureFD sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 42 shares — an estimated $7K sold.

SignatureFD first reported a position in XLRN in Q2 2019 and held it in 9 quarters. The position peaked at $11K in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • SignatureFD reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • SignatureFD sold 42 Acceleron Pharma shares in Q4 2021, an estimated $7K.
  • SignatureFD first reported a position in Acceleron Pharma in Q2 2019 and held it in 9 quarters.
  • SignatureFD's Acceleron Pharma position peaked at $11K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.